<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-FQZX8RMW</identifier><date>2010</date><creator>Abram, Tjaša</creator><creator>Ignatov, Nataša</creator><relation>documents/doc/F/URN_NBN_SI_doc-FQZX8RMW_001.htm</relation><relation>documents/doc/F/URN_NBN_SI_doc-FQZX8RMW_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-FQZX8RMW_001.txt</relation><format format_type="issue">2</format><format format_type="volume">61</format><format format_type="type">article</format><format format_type="extent">str. 91-94</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">24149031</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-FQZX8RMW</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">antipsihotiki</subject><subject language_type_id="slv">duševne bolezni</subject><subject language_type_id="slv">farmacevtska skrb</subject><title>Farmacevtska skrb pri duševnih boleznih</title></Record>